IBBJ Defiance Nasdaq Junior Biotechnology ETF

No holdings information is available in our database.

IBBJ Defiance Nasdaq Junior Biotechnology ETF

Seeks to track, before fees and expenses, the NASDAQ Junior Biotechnology Index. The Index is designed to track the performance of common stocks and ADRs listed on The Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark. To be eligible for inclusion in the Index, a security must meet the following criteria: 1) Be a member of the Nasdaq Biotechnology Index; and 2) have a market capitalization that is less than $5 billion.

$29.87  0.00 (0.00%)
As of 12/02/2021 16:00:00 EST     IEX book   CBOE book


ETF Information
Sponsor:     Defiance ETFs
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  
Leverage factor:  1.00
Inception date:  08/04/2020
Index tracking method: Passive replication
Current yield:  1.00%
Historical average yield:  0.72%
Market cap:  $8,242,210
Average volume:  3,269
Fees:     0.4500%

Index Information
NASDAQ Junior Biotechnology Index
Index symbol:  NBIJR
Provider:   NASDAQ OMX
Index weighting:   Market capitalization
Index inception date:  04/30/2020
Backtesting data exists:   Yes
Number of holdings:  176  (as of 08/11/2020)
Rebalanced:  Quarterly
Reconstituted:  Annually

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy